SAM #75N98026Q00382

NIH Solicitation for Bio-Rad ChemiDoc MP Imaging System and Accessories

This procurement opportunity is for a specialized molecular biology imaging system for NIH research: - Government Buyer: - National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), Department of Health and Human Services - OEMs and Vendors: - Bio-Rad (primary OEM, manufacturer of ChemiDoc MP Imaging System) - Government Scientific Source, Inc. (referenced as alternate vendor for pricing) - Products/Services Requested: - ChemiDoc MP Imaging System (Bio-Rad, catalog #12003154), quantity: 1 - Includes White and Blue for ChemiDoc MP/ChemiDoc Imaging Systems - StarBright Blue 700 Goat Anti-Rabbit IgG, 80 µl - hFAB Rhodamine Anti-Tubulin Primary Antibody, 40 µl - Unique/Notable Requirements: - Brand name or equal solicitation, but Bio-Rad is preferred for compatibility with existing lab platforms - System must support chemiluminescent and fluorescent blot imaging, high-sensitivity, reproducible imaging for protein and nucleic acid analyses - Delivery required within 7 days - Place of Performance/Delivery: - NIH OLAO contracting office: 6011 Executive Blvd., Suite 503L, Bethesda, MD 20892 - Research lab delivery: 6701 Rockledge Drive, Bethesda, MD 20817 - Bio-Rad facility (manufacturer): 2000 Alfred Nobel Drive, Hercules, CA 94547

Description

COMBINED SYNOPSIS / SOLICITATION 

Action Code: Combined Synopsis/Solicitation Date: June 1 Year: 2026 Contracting Office Zip Code: 20892 Classification Code: 6640 Contracting Office Address: 6701 Rockledge Drive Bethesda, MD 20817 Subject/Title: ChemiDoc™ MP Imaging System Solicitation Number: 75N98026Q00382 Closing Response Date: June 15, 2026 @ 9am. Eastern Daylight Time (EDT) Contact Point(s): Towanda Daniels, Purchasing Agent Contract Award Type: Firm Fixed Price Contract Award: TBD Contract Award Dollar Amount: TBD Contract Line Item Number(s): TBD Contractor Award Date: TBD Contractor Name: TBD Brand Name or Equal Acquisition (FAR 52.211-6): Yes Description: See attached.   PURCHASE DESCRIPTION

<p>1. <strong>Statement of Need and Purpose</strong>: The research lab of Dr. Chittiboina requires a ChemiDoc&trade; MP Imaging System to reliably document and quantify results from routine molecular biology workflows, including chemiluminescent and fluorescent blot imaging and gel documentation. This instrument will provide high-sensitivity, reproducible imaging needed for accurate data capture, compliance-ready recordkeeping, and efficient experiment throughput. Purchasing the system from BioRad supports continuity with established Bio-Rad platform compatibility and service/support expectations for lab operations. Dr. Chittiboina intend to buy this instrument to fulfil the research requirements.</p>

<p>2. <strong>Background Information and Objective</strong>: The intent of this order is to purchase the ChemiDoc&trade; MP Imaging System manufactured by Bio-Rad, 2000 Alfred Nobel Drive, Hercules, CA 94547. Current imaging access is limited and/or relies on older shared equipment, creating bottlenecks and variability in data acquisition for protein and nucleic acid analyses. The objective of acquiring the ChemiDoc&trade; MP Imaging System is to strengthen the lab&rsquo;s capability to standardize imaging conditions, improve quantitative accuracy, and reduce turnaround time for experimental documentation. This will enhance the quality and traceability of research outputs and support ongoing and future studies requiring robust gel and blot imaging. The ChemiDoc MP Imaging System is a full-feature, best in class instrument for imaging and quantifying nucleic acid and protein in gels and western blots. It is capable of imaging fluorescent western blots (RGB, far-red, near-IR), chemiluminescent western blots, all common nucleic acid and protein gel stains, plus stain-free gels.</p>

<p><strong>Generic Name of Product</strong>: Catalog # 12003154: ChemiDoc&trade; MP Imaging System. Includes: White and Blue for ChemiDoc&trade; MP/ChemiDoc Imaging Systems, StarBright Blue 700 Goat Anti- Rabbit IgG, 80 &mu;l, hFAB&trade; Rhodamine Anti-Tubulin Primary Antibody 40 &mu;l</p>

<p></p>

<p><strong>Purchase Description</strong>: Manufactured by Bio-Rad, 2000 Alfred Nobel Drive, Hercules, CA 94547.</p>

<p><strong>Salient characteristics</strong>: These items are manufactured only by BIORAD. We have the quote from Government Scientific Source, Inc for the same item with a price difference. We prefer to place the order to BIORAD as the company is providing a cheaper price than GSS.</p>

<p>4. Quantity: One item</p>

<p>5. Delivery Date: As soon as possible within a frame of 7 days.</p>

<p>6. Period of Performance: Not applicable</p>

<p>7. Option(s): Not applicable</p>
</li>
<li>&ldquo;This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.&rdquo;</li>
<li>The solicitation number and a statement that the solicitation is issued as a request for quote (RFQ).</li>
<li>The solicitation document, the incorporated provisions, and clauses are those in effect through Federal Acquisition Circular, <strong>FAC Number:</strong>&nbsp;2026-01&nbsp;<strong>Effective Date:</strong>&nbsp;03/13/2026</li>

This solicitation is being released unrestricted. The NAICS code is 334516, and the small business size standard is 1,000. This acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.

The Statement of Need and any terms and conditions relevant to the requirement are included as attachments.

The provisions at FAR Clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition. The following addendum related to the Instructions to Offerors is included:

Addendum to FAR Clause 52.212-1, Instructions to Offerors – Commercial Items. Please refer to this addendum for additional attachments, including the Statement of Work and other relevant information.

Evaluations will be conducted in accordance with the provision at FAR Clause 52.212-2. Offerors will be evaluated as follows:

Evaluation-Commercial Items (Oct 2014)

The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

Technical:  Past Performance Cost

All evaluation factors other than cost or price, when combined are significantly more important than cost or price.

Written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

Please refer to the addendum for additional evaluation information.

Each Offeror must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, with its offer.

Please note, each Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically via the System for Award Management (SAM) website located at

https://www.sam.gov/portal.

FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition. The terms and conditions outlined in the following addendum also apply:

Addendum to FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items. Please refer to this addendum for additional terms and conditions related to the requirement.

FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. The full text version of FAR 52.212-5 included in the addenda as Attachment 5 indicate which FAR clauses and provisions are applicable to this acquisition.

Contact Information:

Purchasing Agent: Towanda Daniels

Email: danielt@mail.nih.gov

Place of Contract Performance: Bethesda, MD Set-aside Status: N/A

View original listing